안허혈증후군 환자에게 유리체강내 베바시주맙 주입 후 발생한 급격한 시력저하

• 영문명: Acute Visual Loss after Intravitreal Bevacizumab Injection in a Patient with Ocular Ischemic Syndrome
• 발행기관: 대한안과학회
• 저자명: 김진우 윤이나,Jin Woo Kim, MD, Ie Na Yoon, MD
• 간행물 정보: 『대한안과학회지』Ophthalmological Society,volume53,number12, 1893~1897쪽, 전체 5쪽
• 주제분류: 의약학 > 의학일반
• 파일형태: PDF
• 발행일자: 2012.12.15

영문 초록

Purpose: To report a patient with ocular ischemic syndrome who suffered from sudden decrease in visual acuity after bevacizumab injection. Case summary: A 70-year-old patient visited the Department of Ophthalmology due to progressively decreasing visual acuity in the right eye. Corrected visual acuity in his right eye was 0.1 on the first visit; ocular ischemic syndrome was suspected. Despite panretinal photocoagulation, severe iris neovascularization was still present in the right eye. Intravitreal bevacizumab injection was performed to regress the iris neovascularization. One day after injection, iris neovascularization regressed significantly, however, visual acuity was decreased to finger counting. Conclusions: In ocular ischemic syndrome, bevacizumab injection for reduction of iris neovascularization should be carefully considered due to possibility of acute visual loss.

키워드

Intravitreal bevacizumab, Iris neovascularization, Ocular ischemic syndrome